Mechlorethamine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Mechlorethamine, covering 2012-08-09 to 2021-04-19. Get the full timeline:
Most recent: Clinical Trial Update: Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]